tiprankstipranks
Trending News
More News >
Prostatype Genomics AB (SE:PROGEN)
:PROGEN
Sweden Market

Prostatype Genomics AB (PROGEN) Financial Statements

Compare
0 Followers

Prostatype Genomics AB Financial Overview

Prostatype Genomics AB's market cap is currently kr51.49M. The company's EPS TTM is kr-0.397; its P/E ratio is -0.83; Prostatype Genomics AB is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenuekr 594.00Kkr 199.00Kkr 1.36Mkr 683.00Kkr 10.00K
Gross Profitkr -37.62Mkr 1.92Mkr 3.73Mkr 683.00Kkr 2.51M
Operating Incomekr -39.08Mkr -40.85Mkr -39.25Mkr -28.69Mkr -15.55M
EBITDAkr -36.89Mkr -37.40Mkr -38.02Mkr -26.79Mkr -15.46M
Net Incomekr -44.50Mkr -41.05Mkr -41.44Mkr -29.09Mkr -15.63M
Balance Sheet
Cash & Short-Term Investmentskr 9.07Mkr 9.42Mkr 2.68Mkr 11.49Mkr 20.33M
Total Assetskr 50.86Mkr 41.97Mkr 49.22Mkr 30.95Mkr 40.20M
Total Debtkr 0.00kr 67.00Kkr 11.67Mkr 867.00Kkr 1.27M
Net Debtkr -9.07Mkr -9.42Mkr 8.98Mkr -3.94Mkr -8.56M
Total Liabilitieskr 24.33Mkr 8.50Mkr 24.55Mkr 4.80Mkr 4.30M
Stockholders' Equitykr 26.53Mkr 33.47Mkr 24.67Mkr 26.15Mkr 35.91M
Cash Flow
Free Cash Flowkr -24.06Mkr -52.57Mkr -37.70Mkr -27.69Mkr -18.58M
Operating Cash Flowkr -23.80Mkr -44.71Mkr -29.14Mkr -27.69Mkr -16.08M
Investing Cash Flowkr -13.36Mkr -8.36Mkr -8.57Mkr 0.00kr -2.50M
Financing Cash Flowkr 36.83Mkr 59.75Mkr 28.91Mkr 18.85Mkr 23.05M
Currency in SEK

Prostatype Genomics AB Earnings and Revenue History

Prostatype Genomics AB Debt to Assets

Prostatype Genomics AB Cash Flow

Prostatype Genomics AB Forecast EPS vs Actual EPS